Efficacy and safety of rituximab treatment in children with primary glomerulonephritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of rituximab treatment in children with primary glomerulonephritis

Published:2012 Issue:6 Volume:25 Page:1060-1066
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:JN

Author:

Zachwieja Jacek,Silska Magdalena,Ostalska-Nowicka Danuta,Soltysiak Jolanta,Lipkowska Katarzyna,Blumczynski Andrzej,Musielak Anna

Publisher

SAGE Publications

Subject

Nephrology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study;Frontiers in Pharmacology;2024-03-26

2. Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study;Journal of Clinical Medicine;2021-10-26

3. Multicenter analysis of the efficacy and safety of a non‐standard immunosuppressive therapy with rituximab in children with steroid‐resistant nephrotic syndrome;Clinical and Experimental Pharmacology and Physiology;2018-12-13

4. Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy;Annals of Pharmacotherapy;2018-10-08

5. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS;Clinical Journal of the American Society of Nephrology;2016-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP